Which of the following antianginal agents is a beta-adrenoceptor-blocking drug:

Questions 265

ATI RN

ATI RN Test Bank

ATI Pharmacology Across the Lifespan Questions

Question 1 of 5

Which of the following antianginal agents is a beta-adrenoceptor-blocking drug:

Correct Answer: C

Rationale: In the context of pharmacology, understanding the mechanisms of action of different classes of drugs is crucial for safe and effective prescribing. In this question from the ATI Pharmacology Across the Lifespan exam, the correct answer is C) Atenolol. Atenolol is a beta-adrenoceptor-blocking drug, also known as a beta-blocker. Beta-blockers work by blocking the action of adrenaline on beta receptors in the heart, leading to a decrease in heart rate and contractility. This class of drugs is commonly used in the management of angina, hypertension, and other cardiovascular conditions. Now, let's examine why the other options are incorrect: A) Dipyridamole: Dipyridamole is a coronary vasodilator and an antiplatelet agent used in the prevention of blood clots. It does not belong to the beta-blocker class. B) Validol: Validol is a medication used for the symptomatic treatment of angina pectoris and is derived from menthol. It is not a beta-blocker. D) Alinidine: Alinidine is a centrally acting antihypertensive agent that acts on alpha-2 adrenergic receptors. It is not a beta-blocker. Educationally, knowing the specific properties and mechanisms of action of different drug classes is essential for healthcare professionals to make informed decisions when selecting the most appropriate medication for a patient's condition. Understanding the distinctions between various antianginal agents ensures the safe and effective management of cardiovascular disorders.

Question 2 of 5

Which of the following drugs is related to anticoagulants and may be useful in disorders of cerebral circulation?

Correct Answer: D

Rationale: The correct answer is D) Heparin. Heparin is an anticoagulant that is commonly used in the treatment and prevention of blood clots. It works by inhibiting the clotting factors in the blood, thus preventing the formation of clots. In disorders of cerebral circulation, such as stroke or transient ischemic attacks (TIAs), where blood clots can obstruct blood flow to the brain, anticoagulants like heparin are crucial in preventing further complications. A) Aspirin is a nonsteroidal anti-inflammatory drug (NSAID) that has antiplatelet effects, meaning it can help prevent the formation of blood clots by inhibiting platelet aggregation. While aspirin is commonly used for its antiplatelet properties, it is not classified as an anticoagulant like heparin. B) Cinnarizine is a calcium channel blocker that is mainly used to treat symptoms of vertigo and motion sickness. It does not possess anticoagulant properties and is not typically used in disorders of cerebral circulation. C) Nicergoline is a medication that is used to improve cognitive function and blood flow in patients with age-related cognitive decline or dementia. It is not an anticoagulant and is not indicated for the treatment of disorders of cerebral circulation. In an educational context, understanding the mechanisms of action of different medications is crucial for healthcare professionals to make informed decisions when managing patients with various conditions. Knowing which drugs are anticoagulants and their specific uses in different clinical scenarios, such as disorders of cerebral circulation, can significantly impact patient outcomes and safety.

Question 3 of 5

The derivative of lysergic acid for migraine attack prevention is:

Correct Answer: B

Rationale: The correct answer is B) Methysergide. Methysergide is a derivative of lysergic acid and is commonly used for migraine attack prevention. Methysergide works by blocking serotonin receptors, which helps to reduce the frequency and intensity of migraines. A) Metoclopramide is a medication used to treat nausea and vomiting, particularly in migraine attacks. It works by blocking dopamine receptors and has no direct relation to being a derivative of lysergic acid for migraine prevention. C) Sumatriptan is a medication used to treat acute migraine attacks by constricting blood vessels in the brain and blocking pain pathways. It is not a derivative of lysergic acid like Methysergide. D) Ergotamine is another medication used for treating migraines. It works by constricting blood vessels in the brain. However, it is not a derivative of lysergic acid like Methysergide. Educational Context: Understanding the pharmacology of migraine medications is crucial for healthcare professionals. Methysergide's mechanism of action as a derivative of lysergic acid provides a targeted approach for preventing migraine attacks. Knowing the differences between various migraine medications helps healthcare providers make informed decisions when managing patients with migraines.

Question 4 of 5

All of the following statements about growth hormone are true, EXCEPT:

Correct Answer: D

Rationale: In understanding the rationale behind the correct answer (D) in this question about growth hormone, it is important to consider the physiological effects of growth hormone on bone growth. Growth hormone is crucial for stimulating growth in children by promoting the proliferation of chondrocytes in the epiphyseal plates of long bones. However, once the epiphyses have fused and growth plates have closed, the potential for bone growth ceases. Therefore, administering growth hormone to individuals with closed epiphyses would not result in an increase in height but may instead lead to adverse effects like joint pain and edema. Regarding the incorrect options: A) This statement is true as growth hormone can indeed stimulate the synthesis or release of somatomedins (IGF-1), which mediate many of the growth-promoting effects of growth hormone. B) Low levels of insulin-like growth factor (IGF)-1 are associated with dwarfism because IGF-1 is a key mediator of the growth-promoting effects of growth hormone. C) Hypersecretion of growth hormone can lead to acromegaly, a condition characterized by excessive growth of bones and tissues, especially in the face, hands, and feet. In an educational context, understanding the role of growth hormone is essential for healthcare professionals, especially in fields like endocrinology and pediatrics. By grasping the effects of growth hormone on growth and development, providers can better assess and manage conditions related to growth hormone dysregulation, such as dwarfism or acromegaly. This knowledge is critical for providing safe and effective care to patients across the lifespan.

Question 5 of 5

Thyroid stimulating hormone regulates the following:

Correct Answer: D

Rationale: Thyroid stimulating hormone (TSH) plays a crucial role in regulating thyroid function. The correct answer is D) All of the above. TSH regulates the entire process of thyroid hormone production. Here's why: A) Iodine uptake: TSH stimulates the thyroid gland to take up iodine from the bloodstream, which is essential for the synthesis of thyroid hormones. B) Biosynthesis of iodothyroglobulin: TSH promotes the synthesis of thyroglobulin, a protein in the thyroid gland that binds to iodine to form thyroid hormones. C) Release of thyroid hormone into the plasma: TSH triggers the release of thyroid hormones (T3 and T4) from the thyroid gland into the bloodstream, where they can exert their effects on various body tissues. Why the other options are incorrect: A) Iodine uptake and biosynthesis of iodothyroglobulin are steps in the process regulated by TSH, so selecting only one of these options would be incomplete. C) TSH directly influences the release of thyroid hormones into the plasma, so choosing this option alone would overlook the comprehensive role of TSH in the entire process. Educational context: Understanding the regulation of thyroid function by TSH is essential in pharmacology as it helps healthcare providers comprehend how thyroid disorders develop and how medications can be used to manage them. This knowledge is vital in clinical practice when treating patients with thyroid diseases.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions